📰 GPCR Weekly News, September 18 to 24, 2023
Hi readers! Take a few minutes and dive into our GPCR coverage!
Our recent Dr. GPCR Symposium about 'GPCRs as Therapeutic Modalities' rocked it! A huge thank you to our amazing speakers and everyone who showed up. If you couldn't make it, no sweat – our premium members can always go back and watch the recorded talks at any time here. For attendees, kindly spare a moment to complete our survey.
Save the dates:
November 2 - 4: We're proud sponsors of the GPCR Retreat and can't wait to meet you there! Registration is now closed, but you can join the waitlist by emailing gpcrretreat@uottawa.ca. If you're already registered, kindly use the provided form to submit your poster abstracts. Short talk selections will be announced soon. Abstract submissions close on October 2nd. We are also looking for a new logo for this iconic event. Submit your logo design by November 1st. You don't need to be registered to participate. All information is available on the Logo Contest page.
Access exclusive insights by subscribing to the Dr. GPCR Newsletter!
Dive into the Classified GPCR News from September 18th to 24th, 2023.
GPCR Activation and Signaling
Rules and mechanisms governing G protein coupling selectivity of GPCRs
Location-biased activation of the proton-sensor GPR65 is uncoupled from receptor trafficking
GPCR Binders, Drugs, and more
GPCRs in Cardiology, Endocrinology, and Taste
Structural and functional analysis of salivary intercalated duct cells reveals a secretory phenotype
Mesenchymal stromal cell secretory molecules improve the functional survival of human islets
GPCRs in Neuroscience
GPCRs in Oncology and Immunology
CaaX-motif-adjacent residues influence G protein gamma (Gγ) prenylation under suboptimal conditions
Methods & Updates in GPCR Research
Reviews, GPCRs, and more
Structural and Molecular Insights into GPCR Function
Industry News
Inside the FDA's Form 483 findings at Novo Nordisk's North Carolina semaglutide plant
AI can help to speed up drug discovery — but only if we give it the right data
Inversago Pharma divulges new cannabinoid CB1 receptor antagonists
Addex mGlu2 NAM Cognition Program Receives €4 Million Grant
Confo Therapeutics Appoints Stephen Dowd As Chief Business Officer
Call for GPCR Papers
GPCR Events, Meetings, and Webinars
October 2 - 3, 2023 | Celebrating Robert J. Lefkowitz's Career at Duke
October 3, 2023, | FREE Seminar: Changing paradigm on Therapeutics targeting Membrane Proteins: from antigen production to candidate validation
November 2 - 4, 2023 | GPCR Retreat- Registration Closed
February 3 - 7, 2024 | SLAS2024 International Conference and Exhibition
March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar
March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference
May 27 - 29, 2024 | SLAS Europe 2024 Conference and Exhibition